The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety, efficacy, and pharmacokinetics (PK) results of KN046 (bispecific anti-PD-L1/CTLA4) from a first-in-human study in subjects with advanced solid tumors.
 
Jermaine Coward
Honoraria - MSD; Takeda
Consulting or Advisory Role - MSD; Takeda
Travel, Accommodations, Expenses - MSD; Takeda
 
Vinod Ganju
Honoraria - Janssen; Pfizer; Roche
 
Ramin Behzadigohar
No Relationships to Disclose
 
Kenneth Kwong
Leadership - Alphamab
Consulting or Advisory Role - Alphamab
 
June Xu
Employment - Alphamab
Stock and Other Ownership Interests - Sanofi; WuXi AppTec
 
Hardy Van
Employment - Alphamab
Stock and Other Ownership Interests - Alphamab
 
Paul Kong
Employment - Alphamab
Leadership - Alphamab
Stock and Other Ownership Interests - Alphamab
 
Fei Yang
Employment - Alphamab
Stock and Other Ownership Interests - Alphamab
 
Lisa Chen
Employment - Alphamab
 
Kangping Guo
Employment - Suzhou Alphamab
 
Mei Liu
Employment - Suzhou Alphamab
 
Danming Zhu
Employment - Suzhou Alphamab
 
Lara Kristina Donato
Employment - IQVIA
Consulting or Advisory Role - IQVIA
Research Funding - IQVIA
Travel, Accommodations, Expenses - Astellas Medivation; Daiichi Sankyo; IQVIA; Merck Serono
 
Ting Xu
Employment - Alphamab
Leadership - Alphamab
Stock and Other Ownership Interests - Alphamab
 
Gary Edward Richardson
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Fosun Pharma (Inst); Merck (Inst); Novotech (Inst); Pfizer (Inst); Roche/Genentech (Inst); Shanghai Henlius Biotech (Inst); Suzhou Alphamab (Inst); Takeda (Inst)